Skip to content
Thursday, October 22, 2026 Market moodNeutral−3.2
Sign in
GlideslopeGlideslopeGlideslope AI-powered market news
GlideslopeGlideslopeGlideslope
Market mood−3.2
Breaking
CNBC TOP STORIES Nvidia CEO Jensen Huang says neocloud demand is 'off the charts' but capital is scarce Strong Bullish MOTOR1 Honda's Mitsubishi-Based Truck Is Official, Coming In 2028 Neutral WIRED Meta’s Ad Sales Are Suffering Now That Europeans Can Pick Less Personalization Neutral BUSINESS INSIDER Elon Musk says training Tesla's Optimus robot is like raising a toddler Neutral NEW YORK TIMES BUSINESS Why Many Voters Are Unhappy With the Economy Pessimistic THE GUARDIAN US NEWS Meet the volunteers who will observe Trump’s election monitors during the midterms Bullish CNBC TOP STORIES New bipartisan bill aims to speed up clinical trials for rare disease treatments Neutral WIRED I Worked for a Whole Day Using Only the iPhone Duo. Here’s How It Went Neutral CBS NEWS Idaho mom who blamed vaccines for twins' deaths facing death penalty Pessimistic FOX NEWS WORLD Macron has one more chance to save the country or ‘it’s lost for France,’ business owner … Bearish ABC NEWS A truckers’ protest halts the production of Italy's famed buffalo mozzarella Pessimistic WIRED They Believe 2020 Was Stolen. They Could Be in Charge of Elections in 2028 Bearish ECONOMIST INTERNATIONAL The surprising popularity of AI Neutral THE GUARDIAN US NEWS Russia bombards Kyiv with missiles – hours after agreeing to resume talks with Ukraine Bearish ABC NEWS World shares retreat as report of damage to oil tankers pushes oil prices higher Bearish CONSTRUCTION NEWS UK Research exposes patchy use of whole-life carbon assessments Bullish WIRED Greenlight Family Hub (2026): Finally, a Digital Wall Calendar With a Voice Assistant Neutral FOREIGN POLICY Could AI Disinformation Disrupt the Midterms? Bullish THE GUARDIAN US NEWS Experts alarmed by ‘less transparent’ CDC as US measles deaths rise Bullish THE GUARDIAN US NEWS In reliably blue Minnesota, could Democrats do the unthinkable and lose a Senate seat? Optimistic CNBC TOP STORIES Nvidia CEO Jensen Huang says neocloud demand is 'off the charts' but capital is scarce Strong Bullish MOTOR1 Honda's Mitsubishi-Based Truck Is Official, Coming In 2028 Neutral WIRED Meta’s Ad Sales Are Suffering Now That Europeans Can Pick Less Personalization Neutral BUSINESS INSIDER Elon Musk says training Tesla's Optimus robot is like raising a toddler Neutral NEW YORK TIMES BUSINESS Why Many Voters Are Unhappy With the Economy Pessimistic THE GUARDIAN US NEWS Meet the volunteers who will observe Trump’s election monitors during the midterms Bullish CNBC TOP STORIES New bipartisan bill aims to speed up clinical trials for rare disease treatments Neutral WIRED I Worked for a Whole Day Using Only the iPhone Duo. Here’s How It Went Neutral CBS NEWS Idaho mom who blamed vaccines for twins' deaths facing death penalty Pessimistic FOX NEWS WORLD Macron has one more chance to save the country or ‘it’s lost for France,’ business owner … Bearish ABC NEWS A truckers’ protest halts the production of Italy's famed buffalo mozzarella Pessimistic WIRED They Believe 2020 Was Stolen. They Could Be in Charge of Elections in 2028 Bearish ECONOMIST INTERNATIONAL The surprising popularity of AI Neutral THE GUARDIAN US NEWS Russia bombards Kyiv with missiles – hours after agreeing to resume talks with Ukraine Bearish ABC NEWS World shares retreat as report of damage to oil tankers pushes oil prices higher Bearish CONSTRUCTION NEWS UK Research exposes patchy use of whole-life carbon assessments Bullish WIRED Greenlight Family Hub (2026): Finally, a Digital Wall Calendar With a Voice Assistant Neutral FOREIGN POLICY Could AI Disinformation Disrupt the Midterms? Bullish THE GUARDIAN US NEWS Experts alarmed by ‘less transparent’ CDC as US measles deaths rise Bullish THE GUARDIAN US NEWS In reliably blue Minnesota, could Democrats do the unthinkable and lose a Senate seat? Optimistic
Market Watch · Jun 20, 2026 4:11 PM EDT Healthcare

AbbVie would gain an experimental eczema drug by buying biotech: report

AbbVie is reportedly trying to buy a biotech company that is developing a promising atopic dermatitis drug for $10.9 billion in cash, according to a Financial Times report.

AbbVie would gain an experimental eczema drug by buying biotech: report
Image Market Watch

AI brief

Pulse reads the full article
What happened
Why it matters
What to watch

Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.

Sign in to read the brief
● MACRO ANALYST

Apex+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE